Progress and Challenges of Immunotherapy Predictive Biomarkers for Triple Negative Breast Cancer in the Era of Single-Cell Multi-Omics

Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer with a poor prognosis. Despite conventional treatments, including surgery, radiation, and chemotherapy, the overall response rate to PD-1/PD-L1 immune checkpoint inhibitors remains low, with limited predictive signi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Jiangnan, Guo, Zhikun, Wang, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221869/
https://www.ncbi.nlm.nih.gov/pubmed/37240834
http://dx.doi.org/10.3390/life13051189

Ejemplares similares

Ejemplares similares